These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8092575)

  • 1. [Antifactor VIIIc circulating anticoagulant].
    Lévy G
    Ann Fr Anesth Reanim; 1994; 13(1):142-3. PubMed ID: 8092575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of antifactor VIII circulating anticoagulant after surgery of the biliary tract].
    Huraux C; Hidou M; Perrier JF; Strub P; Briquel ME
    Ann Fr Anesth Reanim; 1994; 13(1):138-41. PubMed ID: 8092573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatoid arthritis and circulating antifactor VIII anticoagulant of immunoglobulinic nature (IgG)].
    Soria J; Soria C; Girard M; Lejeay A; Kahn MF; Guerin C; de Seze S
    Presse Med (1893); 1971 Feb; 79(7):294. PubMed ID: 5576151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors of factor VIIIc and pregnancy. Review of the literature].
    Staikowsky F; Blanchin I; Pineau-Vincent F; Guidet B; Offenstadt G; Gabillet JM
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(6):817-25. PubMed ID: 1822491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of six functional clotting factor VIII:C epitopes by analysis of cross-reactive public idiotypes in murine monoclonal VIII:C inhibitors.
    Tiarks C; Ghalili K; Humphreys RE; Goodall AH; Tuddenham EG; Pechet L
    Thromb Res; 1987 Mar; 45(5):527-37. PubMed ID: 2438801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
    Pfyffer M; Kistler HJ; von Felten A
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1456-9. PubMed ID: 6417777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative disorders of hemostasis caused by antifactor V circulating anticoagulant].
    Leclerc J; Charre S; Tournoys A; Gorski C; Goudemand J
    Ann Fr Anesth Reanim; 1995; 14(3):303-5. PubMed ID: 7486303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhagic syndrome due to an antifactor 8 spontaneous circulating anticoagulant].
    Bauters F; Parquet-Gernez A; Duchatelle P; Goudemand M
    Lille Med; 1971 Dec; 16(10):1430-5. PubMed ID: 5160886
    [No Abstract]   [Full Text] [Related]  

  • 10. Amidolytic end-point methods for factor VIIIC inhibitors.
    Mackie IJ; Seghatchian MJ
    Med Lab Sci; 1982 Oct; 39(4):345-50. PubMed ID: 6817016
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC.
    Erskine JG; Burnett AK; Walker ID; Davidson JF
    Br Med J (Clin Res Ed); 1981 Sep; 283(6294):760. PubMed ID: 6791738
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant.
    Saxena R; Dhot PS; Saraya AK; Singh H; Malhotra OP
    Am J Hematol; 1993 Feb; 42(2):232-3. PubMed ID: 8438888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acquired autoantibodies directed against human factor VIIIc. Treatment of 2 hemorrhagic accidents with porcine factor VIIIc].
    Moreau P; Staikowsky F; Laneelle D; Dellile F; Simonin D; Schiffer C; Laurian Y
    Presse Med; 1993 Mar; 22(10):472-4, 479. PubMed ID: 8511068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatoid arthritis and circulating antifactor 8 anticoagulant of immunoglobulin (IgG) nature. Apropos of a case treated with azathioprine].
    Soria C; Soria J; Girard M; Lejeay A; Kahn MF; Guérin C; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Mar; 38(3):227-34. PubMed ID: 5559721
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA; Zimmerman TS
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1648-52. PubMed ID: 6803246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.
    Taylor L; Ekert H; Dean F
    Haemostasis; 1984; 14(4):296-301. PubMed ID: 6437942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired hemophilia caused by antifactor VIIIc antibodies. Apropos of 3 cases].
    Weiller PJ; Juhan-Vague I; Gola R; Durand JM; Prince-Zucchelli MA; Lefèvre P; Mongin M
    Rev Med Interne; 1983 Dec; 4(4):323-6. PubMed ID: 6420864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery and the acquired inhibitor of factor VIII coagulant].
    Vivin P; Helmer J; Kipper R; Thome M; Briquel ME
    Ann Fr Anesth Reanim; 1986; 5(3):322-5. PubMed ID: 3096169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy.
    Goldsmith JC; Hamilton HE
    Am J Med Sci; 1985 Dec; 290(6):246-8. PubMed ID: 3936359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.